CD200R1
Cell surface glycoprotein CD200 receptor 1
Also known as: CD200R, HCRTR2, MO2R1_HUMAN, MOX2R, OX2R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TD46
- Gene
- CD200R1
- Ensembl
- ENSG00000163606
- Chromosome
- 3
- Canonical length
- 348 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
This gene encodes a receptor for the OX-2 membrane glycoprotein. Both the receptor and substrate are cell surface glycoproteins containing two immunoglobulin-like domains. This receptor is restricted to the surfaces of myeloid lineage cells and the receptor-substrate interaction may function as a myeloid downregulatory signal. Mouse studies of a related gene suggest that this interaction may control myeloid function in a tissue-specific manner. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
348 residues, UniProt reviewed canonical sequence.
>Q8TD46|CD200R1
1 MLCPWRTANL GLLLILTIFL VAEAEGAAQP NNSLMLQTSK ENHALASSSL CMDEKQITQN
61 YSKVLAEVNT SWPVKMATNA VLCCPPIALR NLIIITWEII LRGQPSCTKA YKKETNETKE
121 TNCTDERITW VSRPDQNSDL QIRTVAITHD GYYRCIMVTP DGNFHRGYHL QVLVTPEVTL
181 FQNRNRTAVC KAVAGKPAAH ISWIPEGDCA TKQEYWSNGT VTVKSTCHWE VHNVSTVTCH
241 VSHLTGNKSL YIELLPVPGA KKSAKLYIPY IILTIIILTI VGFIWLLKVN GCRKYKLNKT
301 ESTPVVEEDE MQPYASYTEK NNPLYDTTNK VKASEALQSE VDTDLHTLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CD200R1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 7.5 nTPM
Expression across tissuesHPA
Tissue
- spleen: 7.5 nTPM
- placenta: 5 nTPM
- tonsil: 4.3 nTPM
- lymph node: 4.1 nTPM
- esophagus: 3.6 nTPM
- thymus: 3.1 nTPM
Single-cell type
- hofbauer cells: 84 nCPM
- neutrophil progenitors: 79 nCPM
- cdc: 67 nCPM
- platelets: 43 nCPM
- mast cells: 35 nCPM
- macrophages: 34 nCPM
Immune cell
- basophil: 236 nTPM
- eosinophil: 54 nTPM
- myeloid DC: 23 nTPM
- memory CD4 T-cell: 14 nTPM
- naive CD4 T-cell: 14 nTPM
- memory B-cell: 10 nTPM
Brain region
- choroid plexus: 1.5 nTPM
- cerebral cortex: 1.2 nTPM
- basal ganglia: 0.8 nTPM
- pons: 0.7 nTPM
- amygdala: 0.6 nTPM
- medulla oblongata: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.37
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.7
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- heterotypic cell-cell adhesion
- intracellular signal transduction
- negative regulation of interleukin-6 production
- negative regulation of macrophage migration
- negative regulation of neuroinflammatory response
- negative regulation of T cell migration
- regulation of neuroinflammatory response
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CD200R1 as an antibody target. Whether an autoantibody or antibody against CD200R1 could matter depends on whether native CD200R1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CD200R1 is annotated at the cell surface, where native CD200R1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CD200R1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...